US-based pharma giant Eli Lilly’s blockbuster weight-loss drug, Mounjaro, is set to expand its reach across India through a ...

Cipla will market Eli Lilly’s diabetes and weight-loss drug Mounjaro as Yurpeak in India, enhancing accessibility and ...

Hims & Hers is emerging as a disruptive force in the obesity treatment market, challenging established GLP-1 drug makers. Read why HIMS stock is a Hold.

From discontinued insulin pens to overpriced TB drugs, meet the young South African holding drug makers to account on behalf of patients ...

CHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a randomized trial showed. In this 26-week, double-blind trial of 72 adults, 36% who ...

GLP-1 medications like Ozempic and Wegovy are reducing users' appetites, leading to changes in dining habits. Some restaurants are beginning to adapt by offering smaller portions and specialized menus ...

As GLP-1 medications curb appetites nationwide, will restaurants adapt to smaller cravings? Medications like Ozempic, Mounjaro and Wegovy, originally prescribed for diabetes, are now widely used for ...

But does starting Ozempic really throw off birth control? “I'm not aware of any publications that actually report changes in pregnancy rates themselves,” says Jessica Skelley, a pharmacist at Samford ...

From sagging jowls and sulfurous burps to deflated breasts and surprise pregnancies, the side effects of GLP-1 weight-loss drugs have ranged from subtle to strange. Now, new research suggests that ...